 Veeva Systems has built one of the widest moats in the software industry given the companys dominance of the mission critical pharmaceutical and RD software space. The company is generating significant GAAP earnings and free cash flow along with holding 2.4 billion in cash on the balance sheet making the current environment advantageous instead of threatening. 